Adjuvant chemotherapy in non-small cell lung cancer (NSCLC).
Felip
E
E
Medical Oncology Service, Vall d'Hebron University Hospital, Barcelona, Spain.
Cedrés
S
S
Peralta
S
S
Prat
A
A
D000230:Adenocarcinoma / Q000188:drug therapy / Q000473:pathology; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D017024:Chemotherapy, Adjuvant / Q000379:methods; D002986:Clinical Trials as Topic; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D015201:Meta-Analysis as Topic; D009367:Neoplasm Staging; D011184:Postoperative Period; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis; D016896:Treatment Outcome